Glucotrack Signs Merger Agreement to Acquire Lohkahi Therapeutics
Glucotrack, Inc. entered into an execution copy of a merger agreement with Lohkahi Therapeutics, Inc. dated July 14, 2026. The transaction is subject to customary closing conditions, including regulatory approvals and stockholder approval.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day